Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib von Roschewski, Mark, Phelan, James D., Pittaluga, Stefania, Melani, Christopher, Lakhotia, Rahul, Chabon, Jacob J., Muppidi, Jagan R., Lurain, Kathryn A., Simard, Jillian, Pradhan, Amynah, Hillsman, Amy, Rilko, Madeline, Steinberg, Seth M., Wright, George W., Huang, Da Wei, Yang, Yandan, Lionakis, Michail S., Bagaev, Alexander, Postovalova, Ekaterina, Meerson, Mark, Kudryashova, Olga, Kotlov, Nikita, Fowler, Nathan H., Kurtz, David M., Alizadeh, Ash A., Jaffe, Elaine S., Staudt, Louis M., Wilson, Wyndham H.

Volltext